186 related articles for article (PubMed ID: 34641674)
1. A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease.
Jia Z; Yuan X; Wei JA; Guo X; Gong Y; Li J; Zhou H; Zhang L; Liu J
ACS Appl Mater Interfaces; 2021 Oct; 13(42):49602-49613. PubMed ID: 34641674
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation.
Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710
[TBL] [Abstract][Full Text] [Related]
3. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.
Walia V; Kaushik D; Mittal V; Kumar K; Verma R; Parashar J; Akter R; Rahman MH; Bhatia S; Al-Harrasi A; Karthika C; Bhattacharya T; Chopra H; Ashraf GM
Mol Neurobiol; 2022 Jan; 59(1):657-680. PubMed ID: 34751889
[TBL] [Abstract][Full Text] [Related]
4. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
5. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
Ponne S; Kumar CR; Boopathy R
Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
8. Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer's Disease.
Belkacemi A; Ramassamy C
Cent Nerv Syst Agents Med Chem; 2015; 16(1):37-49. PubMed ID: 26238538
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease.
Zhang L; Zhao P; Yue C; Jin Z; Liu Q; Du X; He Q
Biomaterials; 2019 Mar; 197():393-404. PubMed ID: 30703744
[TBL] [Abstract][Full Text] [Related]
10. Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced β-Amyloid Aggregates.
Yadav R; Murthy RV; Kikkeri R
Chembiochem; 2015 Jul; 16(10):1448-53. PubMed ID: 25944626
[TBL] [Abstract][Full Text] [Related]
11. A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-
Li Y; Lu J; Cao X; Zhao H; Gao L; Xia P; Pei G
Oxid Med Cell Longev; 2020; 2020():7698560. PubMed ID: 32104538
[TBL] [Abstract][Full Text] [Related]
12. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis.
Peng QL; Buz'Zard AR; Lau BH
Brain Res Mol Brain Res; 2002 Jul; 104(1):55-65. PubMed ID: 12117551
[TBL] [Abstract][Full Text] [Related]
13. Functionalized Cerium Dioxide Nanoparticles with Antioxidative Neuroprotection for Alzheimer's Disease.
Hu Y; Guo H; Cheng S; Sun J; Du J; Liu X; Xiong Y; Chen L; Liu C; Wu C; Tian H
Int J Nanomedicine; 2023; 18():6797-6812. PubMed ID: 38026525
[TBL] [Abstract][Full Text] [Related]
14. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
Amin FU; Shah SA; Badshah H; Khan M; Kim MO
J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
[TBL] [Abstract][Full Text] [Related]
15. Protective and anti-oxidative effects of curcumin and resveratrol on Aβ-oligomer-induced damage in the SH-SY5Y cell line.
Yu H; Yamashita T; Hu X; Bian Z; Hu X; Feng T; Tadokoro K; Morihara R; Abe K
J Neurol Sci; 2022 Oct; 441():120356. PubMed ID: 35963200
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Aβ toxicity in Alzheimer's disease by a pyridine amine derivative.
Zhu Z; Yang T; Zhang L; Liu L; Yin E; Zhang C; Guo Z; Xu C; Wang X
Eur J Med Chem; 2019 Apr; 168():330-339. PubMed ID: 30826509
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells.
Liu M; Bai X; Yu S; Zhao W; Qiao J; Liu Y; Zhao D; Wang J; Wang S
Molecules; 2019 Jul; 24(15):. PubMed ID: 31344860
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review.
Phadke AV; Tayade AA; Khambete MP
Chem Biol Drug Des; 2021 Nov; 98(5):713-721. PubMed ID: 34240555
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulphate modified MoS
Tian J; Peng Q; Shen Y; Liu X; Li D; Li J; Guo S; Meng C; Xiao Y
Int J Biol Macromol; 2024 May; 266(Pt 2):131425. PubMed ID: 38583830
[TBL] [Abstract][Full Text] [Related]
20. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
